health pharma news today obesity drugs glp-1 today The next phase of the drug race New Daily GLP-1 Weight Loss
Description
This continuous monitoring and analysis of emerging data are crucial for informing healthcare providers and patients about the potential risks and benefits of GLP-1 medications
Yang J-L, Chen W-Y, Chen S-D
6,7 Sulfonylurea treatment is also associated with hypoglycemia
7 To emphasize this approach to care, the 2020 Standards include a decision cycle for patient-centered glycemic management in type 2 diabetes . The ADA recommends that the decision cycle be undertaken at least once or twice annually to reevaluate patient needs and avoid clinical inertia such that patient-specific treatment goals can be achieved
How quickly do GLP-1s work
Advertisement This was the first cardiovascular outcome trial of an incretin-based therapy with an active comparator, notes Dr
